scholarly journals LONG‐TERM ANALYSES FROM L‐MIND, A PHASE II STUDY OF TAFASITAMAB PLUS LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL)

2021 ◽  
Vol 39 (S2) ◽  
Author(s):  
J Duell ◽  
K. J Maddocks ◽  
E González‐Barca ◽  
W Jurczak ◽  
A. M Liberati ◽  
...  
Keyword(s):  
B Cell ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Large B Cell Lymphoma ◽  
Large B Cell

Long-term results of the R-CEOP90 in the treatment of young patients with chemotherapy-naïve diffuse large B cell lymphoma: A phase II study

2014 ◽  
Vol 55 (10) ◽  
pp. 2387-2388 ◽  
Author(s):  
Qi-Chun Cai ◽  
Yan Gao ◽  
Xiao-Xiao Wang ◽  
Qing-Qing Cai ◽  
Ze-Xiao Lin ◽  
...  
Keyword(s):  
B Cell ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Cell Lymphoma ◽  
Young Patients ◽  
B Cell Lymphoma ◽  
Long Term Results ◽  
Large B Cell Lymphoma ◽  
Large B Cell

Phase II study of CHOP-GR therapy in diffuse large B-cell lymphoma

2012 ◽  
Vol 96 (2) ◽  
pp. 241-246 ◽  
Author(s):  
Sachiya Takemura ◽  
Naoto Tomita ◽  
Hideyuki Koharazawa ◽  
Katsumichi Fujimaki ◽  
Hiroshi Harano ◽  
...  
Keyword(s):  
B Cell ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Large B Cell Lymphoma ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document